Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Early clinical results presented for ABX-IL-8 in psoriasis

Feb. 17, 1999

Fresenius will distribute Genzyme's Sepra products in select European markets

Feb. 17, 1999

Health Canada approves first active wound-healing agent

Feb. 16, 1999

AxyS initiates phase Ib studies of APC-2059 in psoriasis

Feb. 16, 1999

Human Genome Sciences initiates phase II clinical trials of new wound-healing agent

Feb. 15, 1999

Pierre Fabre Dermatologie to commercialize Allergan's Zorac in Europe

Feb. 12, 1999

ADCON-L improves clinical outcome following lumbar discectomy

Feb. 11, 1999

Micrologix Biotech continues preclinical testing on acne drugs

Feb. 8, 1999

Schering discloses new leukotriene antagonists particularly useful as dermatological products

Feb. 3, 1999

Gliatech initiates ADCON-P pivotal clinical trial

Jan. 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...